Skip to main content

MoneyWorks4Me

Medicamen Biotech informs about board meeting

06 Nov 2020 Evaluate

Medicamen Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020, to consider and approve Un-audited Financial Results (Standalone & Consolidated) for the half year ended on September 30, 2020.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1804.20
Dr. Reddys Labs. 1370.40
Cipla 1397.00
Lupin 1970.45
Zydus Lifesciences 1179.25
View more..